Rigel Pharmaceuticals, Inc. (RIGL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 09:42AM EDT. Market open.
| Previous close | 1.2200 |
| Open | 1.2300 |
| Bid | 1.2100 x 200 |
| Ask | 1.2300 x 200 |
| Day's range | 1.2190 - 1.2300 |
| 52-week range | 0.7100 - 1.9600 |
| Volume | |
| Avg. volume | 1,501,516 |
| Market cap | 213.994M |
| Beta (5Y monthly) | 0.98 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
ProPhase Labs (PRPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Rigel (RIGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
© 2024 Yahoo. All rights reserved.